跳至主要内容
临床试验/NCT05547581
NCT05547581尚未招募不适用

Early Detection of Contrast Induced Nephropathy After Coronary Angiography : Predictive Value of Osteopontin

Noura gamal0 个研究点目标入组 155 人开始时间: 2022年12月7日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
155
主要终点
early detection of patients at risk of (CA-AKI) before angiographic procedures

研究概览

简要总结

Early detection of contrast induced nephropathy by using osteopontin as an early marker for prediction

详细描述

People who undergo coronary angiography are at risk of contrast-associated acute kidney injury (CA-AKI) .

The prevention therapy is the main approach to address CA-AKI, minimizing the volume of contrast media and intravenous hydration before and after the procedure which may not be appropriate for those with heart failure .

Given limited treatment options once CA-AKI develops and an unfavourable associated prognosis, early identification of those at risk of CA-AKI is crucial.

Also, there is studies was linking CA-AKI with a higher mortality rate and adverse future cardiovascular events, and risk for future CA-AKI events .

Mehran and colleagues described CA-AKI risk score predicting both CA-AKI and cardiovascular events after angiographic procedures.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing coronary with or without intervention between 2022and 2024 were prospectively enrolled at the study.
  • Patients were referred for angiography for various acute and nonacute indications, including acute coronary syndromes, heart failure, abnormal stress tests, stable chest pain, claudication, and routine preoperative evaluation.
  • Patient with CKD stage 1 or 2 only

排除标准

  • Pt has history of contrast induced nephropathy before. Patient known to have Chronic kidney disease stage 3A upto 5D Pt has contraindication for coronary angiograghy.

结局指标

主要结局

early detection of patients at risk of (CA-AKI) before angiographic procedures

时间窗: Baseline

Early prediction of CIN for early prevention and proper management

次要结局

未报告次要终点

研究者

发起方
Noura gamal
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Noura gamal

Director,assistant lecture,principle investigator.clinical physician.

Assiut University

相似试验